Patent & IP news for March 12, 2015

"That man is not your maker": hard times for Blurred Lines from ipkitten.blogspot.com

What with Kats scattering in all directions to cover so many exciting developments, it's always good to know that the IPKat, Merpel and the blogging team have friends on whom they can rely.  One ...

Share via E–mail | Twitter | Facebook

EPO crisis: what actually happened at the December Administrative Council meeting? Part I from ipkitten.blogspot.com

Merpel has been rather busy this week, but has finally had the chance to peruse the Minutes of the European Patent Office's Administrative Council meeting from last December, which came her way recently.  Regular ...

Share via E–mail | Twitter | Facebook

EPO crisis: what actually happened at the December Administrative Council meeting? Part II from ipkitten.blogspot.com

Following on from Part I of this post, this is what is minuted with regard to the "New Career System".

The President said the new career system had been discussed intensively in the BFC, which ...

Share via E–mail | Twitter | Facebook

Does an invention have a sole? CJEU rules in telmisartan SPC dispute from ipkitten.blogspot.com

Today's the day that many pharmaceutical patent term extension-watchers have been waiting for with feelings of optimism or anxiety: the day on which the Court of Justice of the European Union (CJEU) delivered its ...

Share via E–mail | Twitter | Facebook

Transparency and the Trans-Pacific Partnership Treaty from www.patentdocs.org

By Kevin E. Noonan -- Shrouded in secrecy and spawning more than its share of dystopian conspiracy theories, the Trans-Pacific Partnership (TPP) treaty -- being negotiated by the U.S. and eleven foreign governments (Australia, Brunei, Canada ...

Share via E–mail | Twitter | Facebook

Some almost-forgotten, still-pending Android-related patent cases involving Apple, Microsoft from www.fosspatents.com

Long gone are the days (in 2010 and 2011) when major players in the smartphone industry brought seemingly-spectacular patent infringement suits against each other. Such cases have still been filed ever since, but less frequently ...

Share via E–mail | Twitter | Facebook

Conservatives rally against Goodlatte's Innovation Act from ipbiz.blogspot.com


The Washington Times discusses conservative opposition to the
Innovation Act:

--

Conservatives are stepping up their opposition to a Republican-backed patent-reform bill in Congress that they warn will trample on American inventors’ rights in the name ...

Share via E–mail | Twitter | Facebook

Plaintiff’s Desire for “Payback” and Litigation Abuse Warrant Fee Award Under § 285 from docketreport.blogspot.com

The court granted defendant's motion for attorneys' fees under 35 U.S.C. § 285 following jury and bench trials because of the lack of strength of plaintiff's case and its litigation tactics. "[E ...

Share via E–mail | Twitter | Facebook

New IP finance toolkit from UK IP Office from www.athenaalliance.org

In previous postings, I reported on the efforts of the UK Intellectual Property Office to foster the utilization of IP as a financial asset. In 2013 I posted an item on their report on Banking ...

Share via E–mail | Twitter | Facebook

Congress to Consider Alternative Patent Litigation Reform Bill from patlit.blogspot.com

Last month, the so-called “Innovation Act of 2015” (H.R. 9) was introduced in the U.S. House of Representatives. That bill proposed several reforms of the patent system, including restrictions on patent litigation such ...

Share via E–mail | Twitter | Facebook

MVS Filewrapper® Blog: Lost Profit Damages Require Actual Sales by Patentee from www.filewrapper.com

Post by Jonathan Kennedy

 

The award of damages in patent infringement cases is governed by 35 U.S.C. § 284.  The statute provides "[u]pon finding for the [patent owner] the court shall award the ...

Share via E–mail | Twitter | Facebook

PCT/US2014/053800 to MIT titled TUNING MICROBIAL POPULATIONS WITH PROGRAMMABLE NUCLEASES from ipbiz.blogspot.com


The abstract:

--
Various aspects and embodiments of the invention are directed to methods and compositions for reversing antibiotic resistance or virulence in and/or destroying pathogenic microbial cells such as, for example, pathogenic bacterial cells ...

Share via E–mail | Twitter | Facebook

PTAB analogous art problem solved advantage reverse from allthingspros.blogspot.com

Board finds non-analogous art when Examiner mistakes advantage of reference compound with problem solved by reference

Takeaway: In appealing an obviousness rejection of a semiconductor device, the Applicant argued that one of the references was ...

Share via E–mail | Twitter | Facebook